[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel; liso-cel) as a pot...[ Price : $8.95]
FDA accepts a Lantheus NDA for a new formulation of its Pylarify F 18 prostate-specific membrane antigen imaging agent.[ Price : $8.95]
FDA issues an early alert based on a Boston Scientific letter to customers about certain Endotak Reliance defibrillation leads tha...[ Price : $8.95]
FDA issues an alert after Boston Scientific notified customers that all lots of certain Watchman Access Systems have updated use i...[ Price : $8.95]
An FDA Early Alert says Medline ReNewal recommends that some reprocessed St. Jude electrophysiology catheters be quarantined due t...[ Price : $8.95]
FDA grants accelerated approval for Jazz Modeyso to treat diffuse midline glioma.[ Price : $8.95]
FDA publishes the FY 2025 Quarter 2 update to the CBER/CDER Data Standards Program Action Plan.[ Price : $8.95]
FDA grants Clarametyx Biosciences both fast track and qualified infectious disease product designations for its lead therapeutic c...